SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

US FDA postpones Celltrion's Remicade biosimilar review meeting

The US FDA has delayed an advisory committee review of Celltrion's Remicade (infliximab) biosimilar after asking the South Korean drugmaker for more information.

Apotex's Neupogen biosimilar could be battling Sandoz's copycat in the US in 2015

Apotex’s Neupogen (filgrastim) copycat Grastofil could be on US pharmacy shelves as early as December, after the US Food and Drug Administration (FDA) started its review this week.

UK R&D firm patents biologics powder storage technique

XstalBio, a private biopharma services company, has patented the use of stabilisers in the manufacture of dry powders for biopharmaceuticals – an alternative to freeze-drying or spray-drying techniques.

Japanese companies acquire CMO KBI Biopharma

Tokyo-based CMIC Holdings Co., Innovation Network Corporation of Japan (INCJ), and JSR have agreed to acquire KBI Biopharma, a contract development and manufacturing organization with facilities in Durham and Research Triangle Park, North Carolina and Boulder, Colorado. 

Sosei, so good: Heptares' collaborations to continue post takeover

Sosei's takeover will not impact Heptares's antibody tech collaboration with Morphosys according to the UK membrane protein specialist.

Mundipharma associate launches Remsima in UK and preps for wider roll out

Mundipharma’s associate Napp Pharmaceuticals launched Celltrion’s Remicade biosimilar Remisma in the UK today, just 24 hours after the originator lost patent protection.

UK gives $31m to industry-academic biodevelopment collabs

The UK has granted £20m ($31m) to the biotech industry – including Horizon, FujiFilm, and Cobra Biologics, to bring mAb, cell expression, and antibiotic projects to market.

Spotlight

Teva: More biomanufacturing space needed to tap biologics

Teva: More biomanufacturing space needed to tap biologics opportunities

Teva must invest in its biomanufacturing network as the firm’s biologics aspirations grow beyond biosimilars, CEO Erez Vigodman...

Probodies perfect! CytomX raises $20m funding led by Pfizer

Probodies perfect! CytomX raises $20m funding led by Pfizer

The $20m funding led by Pfizer Venture Investments will help advance a platform to make Probodies which...

Novozymes predicts half-life boost for pharma business, but lets long term rev forecast slide on oil prices

Novozymes predicts half-life boost for pharma business, but lets long term rev forecast slide on oil prices

Novozymes finished 2014 with higher pharma revenues thanks in part to GSK's adoption of its albumin half-life...

Sanofi selects B-I to manufacture growing monoclonal antibody pipeline

Sanofi selects B-I to manufacture growing monoclonal antibody portfolio

Sanofi has selected Boehringer-Ingelheim to manufacture monoclonal antibodies in an agreement that extends to the French drugmaker's...

Exclusive extract: 'On Immunity: An Inoculation' by Eula Biss

Exclusive extract: 'On Immunity: An Inoculation' by Eula Biss

In an exclusive extract from her recent book On Immunity: An Innoculation, author Eula Biss describes her...

Ebola: which are the leading vaccine candidates?
INFOGRAPHIC

Ebola: which are the leading vaccine candidates?

BioPharma-Reporter.com's interactive guide to the world's most promising Ebola vaccines.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...